CH699182A1 - bee honey mixtures for dermatological treatment of chronic wounds. - Google Patents
bee honey mixtures for dermatological treatment of chronic wounds. Download PDFInfo
- Publication number
- CH699182A1 CH699182A1 CH01114/08A CH11142008A CH699182A1 CH 699182 A1 CH699182 A1 CH 699182A1 CH 01114/08 A CH01114/08 A CH 01114/08A CH 11142008 A CH11142008 A CH 11142008A CH 699182 A1 CH699182 A1 CH 699182A1
- Authority
- CH
- Switzerland
- Prior art keywords
- honey
- mixture
- dermatological treatment
- chronic wounds
- mix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/624—Nanocapsules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Husbandry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Mixture of honey of honeybees comprises mixture of microbicides and antiinflammatory products and epithelizing agents of which their composition is adapted to the biochemical medium during different stages of healing. ACTIVITY : Vulnerary. MECHANISM OF ACTION : None given.
Description
Introduction:
[0001] La guérison des plaies suit normalement quatre étapes: Homéostasies - Inflammation - Prolifération - Remodelisation [Douglas MacKay and Alan Miller, Nutritional Support for Wound Healing, Alternative Medicine Review, Vol. 8, No 4, 2003]. Pour nos considérations phase 2 et 3 sont les plus importants.
[0002] Phase de l'inflammation (phase destructive) qui provoque par des enzymes spécifiques une lyse des cellules blessées. Des essais ont montré qu'il s'agit au point de vue biochimique des réactions d'oxydation initiées par des radicaux libres et des peroxydes [P. Dubouloz, Sur la formation de peroxydes lipidiques dans la peau après action de divers agents physiques, thèse 097 896, 1954, fac. Des Sciences Univ. de Marseille].
[0003] Phase d'épithelisation (phase proliférative) caractérisée par. la formation du nouveau tissu pour fermer la plaie. Cette phase requiert de préférence un milieu réducteur biochimiquement parlant.
[0004] Certaines maladies, surtout le diabète, perturbent l'équilibre Redox de la guérison. Les plaies restent dans la première phase d'inflammation oxydative et ne guérissent pas. Les cellules ne sont pas aptes de changer de la phase inflammatoire oxydative à la phase d'épitelisation réductive. En plus l'inflammation prolongée expose la plaie aux infections par des mieroorganismes [voir aussi: Jorge de la Torre, The Physiology of Healing of the Chrome Wound, medicine from WebMD, May 26, 2006].
Description de la technique actuelle
[0005] Aujourd'hui le problème de ces plaies chroniques n'est pas encore résolu à la satisfaction des patients.
[0006] Des crèmes et poudres ayant une action bactéricide empêchent une infection des plaies mais ne les peuvent pas guérir complètement.
[0007] Un des remèdes les plus vieux pour accélérer la guérison des plaies superficielles est le miel. Des mélanges du miel avec l'huile de foie de morue et avant depuis l'antiquité avec des résines végétales ont été utilisés et testés récemment [ M. Lofty et al., Combined use of honey, bee propolis and myrrh in healing a deep, infeeted wound in a patient with diabètes mellitus, Brit. Journ. of Biomed. Science, 2006, 63 (4), pages 171-173]. L'activité du miel est relativement restreinte et de ce fait son utilisation a été supplantée par des remèdes plus modernes. Son action est surtout bactéricide et dépend fortement de son origine.
Le miel du tea tree (Manuka - honey) de la Nouvelle Zealande a-montré une activité plus prononcée que d'autres sortes [Shna Abdurahman, M vitro interaction between methcillin-resistant S.aureus and varions types of honey, The Biomédical Scientist, Nov. 2007 Pages 908-909].
[0008] Les acides aminés cysteine, glycine et threonine ont été essayé pour la guérison des plaies [S.G. Harvey and J.R. Gibson, The effects on wound healing of three amino acids - a comparison of two models, Brit. Journ. of Dermat. Vol.lll, Issue s27, page 171, July 1984].
[0009] Un brevet canadien concerne une large gamme des acides aminés pour la guérison des plaies [Can. Pat. No-2 455 776: Composition à base d'acides aminés appropriées en thérapie pour guérir et/ou panser des plaies et des lésions, notamment utilisées dans le domaine de l'ophtalmologie].
Description de l'invention
[0010] Les conclusions théoriques concernant le déséquilibre du système Redox dans des plaies chroniques et mal guérissables nous ont mené vers une combinaison des produits qui sont adaptés aux conditions biologiques et biochimiques de la plaie du début de F inflammation jusqu'à guérison complète. Ces préparations pour traiter la plaie chronique ont d'abord une action à prédominance microbicide' et doivent faciliter le nettoyage de la plaie pour contrôler une infection. Ensuite la composition du mélange traitante va aider au tissu de la plaie de quitter la phase inflammatoire (oxydative) et mduire un milieu antioxydant et réducteur qui est favorable a l'épithelisation et finalement à la guérison complète.
[0011] Depuis l'antiquité le miel des abeilles est utilisé pour le traitement des plaies. Son action connue est surtout bactériostatique. Quelques sortes ont même une action légèrement bactéricide.
[0012] Après l'analyse de beaucoup de sortes de miel nous avons trouvé que le miel en provenance de Lavandula stoechas L. (Rosmaninho) au Portugal montre une action bactéricide presque aussi prononcée que le miel de Manuka et nettement plus forte que d'autres sortes trouvées en Europe.
[0013] A part de cette action bactéricide relativement faible le miel a une action réductrice grâce à sa teneur en monosaccharides (34-41% fructose, 28-35% glucose). Ceci le rend idéal comme base d'application pour des produits sensibles à l'oxydation comme les antioxydants et les vitamines et certains extraits de plantes.
[0014] Les résultats de guérison de ces mélanges nouveaux sont tout à fait extraordinaires et pas connus dans le milieu médical. De ce fait les mélanges décrits en détail par la suite font l'objet de cette demande de brevet.
Exemples de mélanges du miel avec d'autres substances actives pour traiter les plaies chroniques.
Exemple 1: augmentation de l'activité bactéricide du miel avec le nanosilver
[0015]
<tb>Miel<sep>99,0 %
<tb>Sanitized BC A 21-41*<sep>1,0
<tb><sep>100,0
[0016] *Des ions d'argent encapsulés dans une matrice en verre, contient 15% d'argent. Fabricant: Clariant AG, Basel
[0017] Ce mélange peut être appliqué à l'aide d'une spatule sur la plaie, mais peut aussi servir à imbiber des pansements.
Exemple 2: solution miel avec Aloe et nanosilver en suspension
[0018]
<tb>Miel<sep>50,0 %
<tb>Jus d'aloe barbadensis frais, non traité<sep>48,5
<tb>Sanitized BC A 21-41<sep>1,5
<tb>Conservateur<sep>q.s.
[0019] Ce mélange est assez liquide. Pour faciliter l'utilisation sur des plaies on peut faire les applications suivantes:
<tb>a) Spray:<sep>la solution est remplie dans un flacon avec pompe vaporisateur.
<tb>b) Gel:<sep>par adjonction d'un gélifiant la viscosité est fortement augmentée. Le gel résultant est appliqué par une spatule.
Exemple 3: combinaison du miel avec des antioxydants
[0020] Le miel avec son milieu réducteur est idéal pour garder en solution ou suspension des produits sensibles contre l'oxydation. Ceci est le cas avec la plupart des antioxydants et vitamines. Nos essais ont montré que la combinaison du miel avec des antioxydants et des vitamines amène une meilleure guérison et cicatrisation des plaies.
[0021] Les antioxydants sont des substances qui protègent des biomolécules, surtout les acides polyunsaturés des membranes cellulaires et finalement les cellules eux mêmes contre la destruction par l'oxydation. Cette protection est effectuée par l'inactivation des radicaux libres, des peroxydes et des traces de métaux catalytiques (Fer, Cuivre). Détails voir brevet suisse Gunter Holzner CH 695 414 A5, 30.05.2001).
Formule d'application:
[0022]
<tb>Miel<sep>90,0%
<tb>Tocophérol (Coviox -70 de Cognis,Diisseldorf)<sep>10,0
<tb><sep>100,0
Exemple 4: combinaison du miel avec antioxydants, vitamines et acides aminés:
[0023]
<tb>Super miel 1<sep>
<tb>Vitamine E<sep>2,0%
<tb>Miel<sep>89,4
<tb>Essence Girofle<sep>1,6
<tb>Vitamine C<sep>3,0
<tb>Taurine<sep>1,0
<tb>Acides aminés SD<sep>2,0
<tb>Vitamines SD<sep>1,0
<tb><sep>100,0
<tb>Super miel 2<sep>
<tb>Vitamine E<sep>2,5%
<tb>Miel<sep>86,0
<tb>Sanitized BC A 21-41*<sep>0,7
<tb>Essence Girofle<sep>1,6
<tb>Vitamine C<sep>3,0
<tb>Taurine<sep>1,0
<tb>Acides aminés SD<sep>2,0
<tb>Vitamines SD<sep>1,0
<tb>Vitamine D3 1 mio Unités<sep>0,2
<tb>Correspond à 50mg/kg<sep>
<tb>Lécithine tournesol<sep>2,0
<tb><sep>100,0
Exemple 5: Miel gélifié
[0024] Des gélifiants donnant des bons résultats sont les polyacrylates par exemple Cosmedia SP (Na-polyacrylate de Cognis AG, Düsseldorf) ou Aristoflex AVC et Aristoflex HMB (Ammonium-Acryloyldimethyltaurate/VP copolymère de Clariant AG, Basel). Autres gélifiants pourraient être les dérives cellulosiques, les Xanthanes et les dérives du Guar. Comme gélifiants anorganiques on peut utiliser des Montmorillonites (silicates en couches qui gonflent avec de l'eau). Dans la plupart des cas 2-5% gélifiant sont suffisants pour obtenir un gel stable et d'une consistance correcte.
<tb>Gel Miel 2<sep>
<tb>Part A<sep>
<tb>Alcool éthylique 94%<sep>20,0%
<tb>Eau<sep>31,8
<tb>Taurin<sep>1,0
<tb>Aloe 200x extrait lyophilisé<sep>0,5
<tb>Miel<sep>30,0
<tb><sep>
<tb>PartB<sep>
<tb>Propylheptyl Caprylate<sep>12,0
<tb>Dilaurylthiodipropionate<sep>0,5
<tb>Vitamine E<sep>2,0
<tb>Aristoflex AVC<sep>1,5
<tb>Aristoflex HMB<sep>0,7
<tb><sep>100,0
Example 6: miel gélifié avec nanosilver
[0025]
<tb>Gel Miel 3<sep>
<tb>Part A<sep>
<tb>Alcool 94%<sep>20,0%
<tb>Eau<sep>26,0
<tb>Taurin<sep>1,0
<tb>Aloe 200x<sep>0,5
<tb>Miel<sep>30,0
<tb>Vitamines SD (1)<sep>1,0
<tb>Acides aminés SD (2)<sep>2,0
<tb><sep>
<tb>Part B<sep>
<tb>Propylheptyl Caprylate<sep>12,0
<tb>Dilaurylthiodipropionate<sep>0,5
<tb>Sanitized BC A 21-41*<sep>0,6
<tb>Vitamine E<sep>2,0
<tb>Aristoflex AVC<sep>1,5
<tb>Aristoflex HMB<sep>0,7
<tb>Lécithine<sep>2,0
<tb>Vitamine D3<sep>0,2
<tb><sep>100,0
[0026] Fabrication: mélanger séparément Part A et B. Après mélanger les deux parts et bien homogénéiser.
[0027] Les préparations de l'exemple 5 et 6 contiennent moins de miel mais d'avantage des produits cicatrisants et épithelisants. Elles sont destinées pour le traitement de la deuxième phase jusqu à la guérison complète.
(1) Composition des acides aminés SD:
[0028]
<tb><sep>g pro litre solution
<tb>L-Arginine<sep>10,0
<tb>L-Asparagine. H20<sep>2,8
<tb>L-Cystine<sep>2,5
<tb>L-Isoleucine<sep>2,5
<tb>L- Leucine<sep>2,5
<tb>L-Lysine.HCl<sep>2,0
<tb>L-Serine<sep>1,5
<tb>L- Tyrosine<sep>1,2
<tb>L- Proline<sep>1,0
<tb>L-Valine<sep>1,0
(2) Composition des vitamines SD:
[0029]
<tb><sep>g pro litre solution
<tb>Myo-Inositol<sep>3,5
<tb>Chlorure de Choline<sep>0,3
<tb>Acide Folique<sep>0,1
<tb>Niacinamide<sep>0,1
<tb>Pyridoxine HC1<sep>0,1
<tb>Thiamine HC1<sep>0,1
Introduction:
[0001] Wound healing normally follows four stages: Homeostasis - Inflammation - Proliferation - Remodeling [Douglas MacKay and Alan Miller, Nutritional Support for Wound Healing, Alternative Medicine Review, Vol. 8, No. 4, 2003]. For our considerations phase 2 and 3 are the most important.
Phase of inflammation (destructive phase) which causes specific enzymes lysis of injured cells. Tests have shown that it is a biochemical point of view of the oxidation reactions initiated by free radicals and peroxides [P. Dubouloz, On the formation of lipid peroxides in the skin after action of various physical agents, Thesis 097 896, 1954, fac. Science Univ. from Marseille].
[0003] Epithelization phase (proliferative phase) characterized by. the formation of new tissue to close the wound. This phase preferably requires a reducing medium biochemically speaking.
[0004] Certain diseases, especially diabetes, disrupt the redox balance of healing. The wounds remain in the first phase of oxidative inflammation and do not heal. The cells are not able to change from the oxidative inflammatory phase to the reductive epitelization phase. In addition the prolonged inflammation exposes the wound to infections by superorganisms [see also: Jorge de la Torre, The Physiology of Healing of the Chrome Wound, Medicine from WebMD, May 26, 2006].
Description of the current technique
[0005] Today the problem of these chronic wounds is not yet solved to the satisfaction of the patients.
Creams and powders having a bactericidal action prevent infection of wounds but can not heal them completely.
[0007] One of the oldest remedies for accelerating the healing of superficial wounds is honey. Mixtures of honey with cod liver oil and since ancient times with plant resins have been used and tested recently [Lofty et al., Combined use of honey, bee propolis and myrrh in healing a deep, infeeted wound in a patient with diabetes mellitus, Brit. Journ. of Biomed. Science, 2006, 63 (4), pages 171-173]. The activity of honey is relatively limited and therefore its use has been supplanted by more modern remedies. Its action is mostly bactericidal and strongly dependent on its origin.
Tea tree honey (Manuka - honey) from New Zealand has shown more activity than other types [Shna Abdurahman, M vitro interaction between methcillin - resistant S.aureus and varions types of honey, The Biomedical Scientist, Nov. 2007 Pages 908-909].
The amino acids cysteine, glycine and threonine have been tried for healing wounds [S.G. Harvey and J. R. Gibson, The effects on wound healing of three amino acids - a comparison of two models, Brit. Journ. of Dermat. Vol.lll, Issue s27, page 171, July 1984].
[0009] A Canadian patent relates to a wide range of amino acids for healing wounds [Can. Pat. No. 2,455,776: Amino Acid-Based Composition Suitable for Therapy in Curing and / or Dressing Wounds and Lesions, Particularly Used in the Field of Ophthalmology].
Description of the invention
Theoretical conclusions concerning the imbalance of the Redox system in chronic wounds and poorly curable led us to a combination of products that are adapted to the biological and biochemical conditions of the wound from the beginning of inflammation until complete healing. These preparations for treating the chronic wound first have a predominantly microbicidal action and should facilitate the cleaning of the wound to control an infection. Thereafter, the composition of the treating mixture will help the wound tissue to leave the inflammatory (oxidative) phase and provide an antioxidant and reducing medium that is favorable for epithelization and ultimately for complete healing.
Since ancient times honey bees is used for the treatment of wounds. Its known action is mainly bacteriostatic. Some kinds even have a slightly bactericidal action.
After analyzing many kinds of honey we found that the honey from Lavandula stoechas L. (Rosmaninho) in Portugal shows a bactericidal action almost as pronounced as the Manuka honey and significantly stronger than other kinds found in Europe.
Apart from this relatively low bactericidal action honey has a reducing action due to its content of monosaccharides (34-41% fructose, 28-35% glucose). This makes it ideal as an application base for oxidation-sensitive products such as antioxidants and vitamins and some plant extracts.
The healing results of these new mixtures are quite extraordinary and not known in the medical community. As a result, the mixtures described in detail below are the subject of this patent application.
Examples of mixtures of honey with other active substances to treat chronic wounds.
Example 1: Increasing the Bactericidal Activity of Honey with the Nanosilver
[0015]
<tb> Honey <sep> 99.0%
<tb> Sanitized BC A 21-41 * <sep> 1.0
<Tb> <September> 100.0
* Silver ions encapsulated in a glass matrix, contains 15% silver. Manufacturer: Clariant AG, Basel
This mixture can be applied with a spatula on the wound, but can also be used to soak dressings.
Example 2: honey solution with Aloe and nanosilver in suspension
[0018]
<tb> Honey <sep> 50.0%
<tb> fresh aloe barbadensis juice, untreated <sep> 48.5
<tb> Sanitized BC A 21-41 <sep> 1.5
<Tb> Conservative <September> q.s..
This mixture is quite liquid. To facilitate the use on wounds one can make the following applications:
<tb> a) Spray: <sep> the solution is filled into a vial with a spray pump.
<tb> b) Gel: <sep> by adding a gelling agent the viscosity is greatly increased. The resulting gel is applied by a spatula.
Example 3: Combination of honey with antioxidants
Honey with its reducing medium is ideal for keeping in solution or suspension of sensitive products against oxidation. This is the case with most antioxidants and vitamins. Our trials have shown that the combination of honey with antioxidants and vitamins leads to better healing and healing of wounds.
Antioxidants are substances that protect biomolecules, especially the polyunsaturated acids of cell membranes and finally the cells themselves against destruction by oxidation. This protection is carried out by the inactivation of free radicals, peroxides and traces of catalytic metals (iron, copper). Details see Swiss patent Gunter Holzner CH 695 414 A5, 30.05.2001).
Application formula:
[0022]
<Tb> Honey <September> 90.0%
<tb> Tocopherol (Coviox-70 from Cognis, Diisseldorf) <sep> 10.0
<Tb> <September> 100.0
Example 4: Combination of honey with antioxidants, vitamins and amino acids:
[0023]
<tb> Super honey 1 <sep>
<tb> Vitamin E <sep> 2.0%
<Tb> Honey <September> 89.4
<tb> Clove oil <sep> 1,6
<tb> Vitamin C <sep> 3.0
<Tb> Taurine <September> 1.0
<tb> SD <sep> 2.0 amino acids
<tb> Vitamins SD <sep> 1.0
<Tb> <September> 100.0
<tb> Super honey 2 <sep>
<tb> Vitamin E <sep> 2.5%
<Tb> Honey <September> 86.0
<tb> Sanitized BC A 21-41 * <sep> 0.7
<tb> Clove oil <sep> 1,6
<tb> Vitamin C <sep> 3.0
<Tb> Taurine <September> 1.0
<tb> SD <sep> 2.0 amino acids
<tb> Vitamins SD <sep> 1.0
<tb> Vitamin D3 1 mio Units <sep> 0.2
<tb> Corresponds to 50mg / kg <sep>
<tb> Lecithin sunflower <sep> 2,0
<Tb> <September> 100.0
Example 5: Gelled Honey
Gelling agents giving good results are polyacrylates, for example Cosmedia SP (Na-polyacrylate from Cognis AG, Düsseldorf) or Aristoflex AVC and Aristoflex HMB (Ammonium-Acryloyldimethyltaurate / VP copolymer from Clariant AG, Basel). Other gelling agents could be cellulosic drifts, Xanthans and Guar drifts. As inorganic gelling agents can be used Montmorillonites (layered silicates that swell with water). In most cases 2-5% gelling agent is sufficient to obtain a stable gel and of a correct consistency.
<tb> Honey Gel 2 <sep>
<tb> Part A <sep>
<tb> Ethyl alcohol 94% <sep> 20.0%
<Tb> Water <September> 31.8
<Tb> Taurin <September> 1.0
<tb> Aloe 200x freeze-dried extract <sep> 0.5
<Tb> Honey <September> 30.0
<Tb> <September>
<Tb> PartB <September>
<tb> Propylheptyl Caprylate <sep> 12.0
<Tb> dilauryl <September> 0.5
<tb> Vitamin E <sep> 2.0
<tb> Aristoflex AVC <sep> 1.5
<tb> Aristoflex HMB <sep> 0.7
<Tb> <September> 100.0
Example 6: Gel honey with nanosilver
[0025]
<tb> Honey Gel 3 <sep>
<tb> Part A <sep>
<tb> Alcohol 94% <sep> 20.0%
<Tb> Water <September> 26.0
<Tb> Taurin <September> 1.0
<tb> Aloe 200x <sep> 0.5
<Tb> Honey <September> 30.0
<tb> Vitamins SD (1) <sep> 1.0
<tb> Amino acids SD (2) <sep> 2,0
<Tb> <September>
<tb> Part B <sep>
<tb> Propylheptyl Caprylate <sep> 12.0
<Tb> dilauryl <September> 0.5
<tb> Sanitized BC A 21-41 * <sep> 0.6
<tb> Vitamin E <sep> 2.0
<tb> Aristoflex AVC <sep> 1.5
<tb> Aristoflex HMB <sep> 0.7
<Tb> Lecithin <September> 2.0
<tb> Vitamin D3 <sep> 0.2
<Tb> <September> 100.0
Manufacturing: separately mix Part A and B. After mixing the two parts and homogenize well.
The preparations of Example 5 and 6 contain less honey but more healing and epithelizing products. They are intended for the treatment of the second phase until complete healing.
(1) Composition of amino acids SD:
[0028]
<tb> <sep> g pro liter solution
<Tb> L-Arginine <September> 10.0
<Tb> L-asparagine. H20 <September> 2.8
<Tb> L-Cystine <September> 2.5
<Tb> L-Isoleucine <September> 2.5
<tb> L-Leucine <sep> 2.5
<Tb> L-Lysine.HCl <September> 2.0
<Tb> L-Serine <September> 1.5
<tb> L-Tyrosine <sep> 1,2
<tb> L-Proline <sep> 1.0
<Tb> L-Valine <September> 1.0
(2) Composition of the vitamins SD:
[0029]
<tb> <sep> g pro liter solution
<Tb> Myo-Inositol <September> 3.5
<tb> Choline Chloride <sep> 0.3
<tb> Folic acid <sep> 0,1
<Tb> Niacinamide <September> 0.1
<tb> Pyridoxine HC1 <sep> 0.1
<tb> Thiamine HC1 <sep> 0.1
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01114/08A CH699182B1 (en) | 2008-07-17 | 2008-07-17 | Mixtures of bee honey for the dermatological treatment of chronic wounds. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01114/08A CH699182B1 (en) | 2008-07-17 | 2008-07-17 | Mixtures of bee honey for the dermatological treatment of chronic wounds. |
Publications (2)
Publication Number | Publication Date |
---|---|
CH699182A1 true CH699182A1 (en) | 2010-01-29 |
CH699182B1 CH699182B1 (en) | 2012-03-15 |
Family
ID=41620975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH01114/08A CH699182B1 (en) | 2008-07-17 | 2008-07-17 | Mixtures of bee honey for the dermatological treatment of chronic wounds. |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH699182B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012151438A1 (en) * | 2011-05-05 | 2012-11-08 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
WO2014202851A1 (en) * | 2013-06-20 | 2014-12-24 | Melipharm | Healing composition and use thereof |
US20150150930A1 (en) * | 2013-12-02 | 2015-06-04 | Laïd BOUKRAA | Aro-honey starch gel for wounds, burns and skin care |
CN109152716A (en) * | 2016-05-10 | 2019-01-04 | 高露洁-棕榄公司 | Taurine and aloe collaboration anti-irritant composition and method |
WO2019063997A1 (en) * | 2017-09-27 | 2019-04-04 | Brightwake Limited | Compositions for wound treatment |
US10272108B2 (en) | 2011-05-05 | 2019-04-30 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5785972A (en) * | 1997-01-10 | 1998-07-28 | Tyler; Kathleen A. | Colloidal silver, honey, and helichrysum oil antiseptic composition and method of application |
WO2002000269A1 (en) * | 2000-06-30 | 2002-01-03 | Phillip Roy Caskey | The use of honey in wound dressings |
CA2455776A1 (en) * | 2001-08-08 | 2003-02-20 | Professional Dietetics S.R.L. | Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
CH695414A5 (en) * | 2001-05-30 | 2006-05-15 | Guenter Holzner | Cosmetic preparation, useful e.g. for treating aging of human skin, comprises anti-oxidizing, reducing, methylating or protein-diminishing active agents (comprising e.g. combination of hydrophilic and lipophilic molecules) |
WO2008049578A2 (en) * | 2006-10-27 | 2008-05-02 | Cnci Bvba | Method for sterilizing unheated raw honey. a honey-based wound care preparation. a wound care treatment product, and a biscuit based on honey |
WO2008079898A1 (en) * | 2006-12-20 | 2008-07-03 | Pharmwest, Inc. | Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions |
-
2008
- 2008-07-17 CH CH01114/08A patent/CH699182B1/en not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5785972A (en) * | 1997-01-10 | 1998-07-28 | Tyler; Kathleen A. | Colloidal silver, honey, and helichrysum oil antiseptic composition and method of application |
WO2002000269A1 (en) * | 2000-06-30 | 2002-01-03 | Phillip Roy Caskey | The use of honey in wound dressings |
CH695414A5 (en) * | 2001-05-30 | 2006-05-15 | Guenter Holzner | Cosmetic preparation, useful e.g. for treating aging of human skin, comprises anti-oxidizing, reducing, methylating or protein-diminishing active agents (comprising e.g. combination of hydrophilic and lipophilic molecules) |
CA2455776A1 (en) * | 2001-08-08 | 2003-02-20 | Professional Dietetics S.R.L. | Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
WO2008049578A2 (en) * | 2006-10-27 | 2008-05-02 | Cnci Bvba | Method for sterilizing unheated raw honey. a honey-based wound care preparation. a wound care treatment product, and a biscuit based on honey |
WO2008079898A1 (en) * | 2006-12-20 | 2008-07-03 | Pharmwest, Inc. | Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions |
Non-Patent Citations (1)
Title |
---|
Henriques A; Burton N F; Cooper R A, Antibacterial activity of selected Portuguese honeys, Journal of Apicultural Research 2005, Vol. 44, No. 3, Pg. 119-123, 01.11.2005, ISSN 0021-8839, [PREV200510253672] * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012151438A1 (en) * | 2011-05-05 | 2012-11-08 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
US9327029B2 (en) | 2011-05-05 | 2016-05-03 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
US10272108B2 (en) | 2011-05-05 | 2019-04-30 | Celacare Technologies, Llc | Antimicrobial silver hydrogel composition for the treatment of burns and wounds |
WO2014202851A1 (en) * | 2013-06-20 | 2014-12-24 | Melipharm | Healing composition and use thereof |
FR3007291A1 (en) * | 2013-06-20 | 2014-12-26 | Melipharm | CICATRISANTE COMPOSITION AND USE |
US20150150930A1 (en) * | 2013-12-02 | 2015-06-04 | Laïd BOUKRAA | Aro-honey starch gel for wounds, burns and skin care |
CN109152716A (en) * | 2016-05-10 | 2019-01-04 | 高露洁-棕榄公司 | Taurine and aloe collaboration anti-irritant composition and method |
US10709907B2 (en) | 2016-05-10 | 2020-07-14 | Colgate-Palmolive Company | Taurine and aloe synergistic anti-irritant compositions and methods |
CN109152716B (en) * | 2016-05-10 | 2021-07-02 | 高露洁-棕榄公司 | Synergistic anti-irritant compositions and methods of taurine and aloe vera |
US11160996B2 (en) | 2016-05-10 | 2021-11-02 | Colgate-Palmolive Company | Taurine and aloe synergistic anti-irritant compositions and methods |
WO2019063997A1 (en) * | 2017-09-27 | 2019-04-04 | Brightwake Limited | Compositions for wound treatment |
Also Published As
Publication number | Publication date |
---|---|
CH699182B1 (en) | 2012-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230112199A1 (en) | Marine extract compositions and methods of use | |
JP3917370B2 (en) | Skin and tissue protection and / or therapeutic agents | |
CA2227977C (en) | Use in a composition of an extract of at least one labiate | |
US11058735B2 (en) | Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract | |
CH699182A1 (en) | bee honey mixtures for dermatological treatment of chronic wounds. | |
US11564963B2 (en) | Topical compositions, process of large-scale manufacture, and method of use | |
CN104825347B (en) | A kind of medical bio whitening and spot-eliminating dressing and preparation method thereof | |
KR20190001166A (en) | Cosmetic composition for regeneration of skin by using the extract of abeliophyllum distichum | |
KR20120107864A (en) | Composition used for treating skin diseases, preparation comprising said composition and production method therefor | |
KR20220032352A (en) | Shampoo for pets | |
CA3188531A1 (en) | Topical compositions, process of large-scale manufacture, and method of use | |
EP1194136B1 (en) | Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract | |
ES2289600T3 (en) | AGENT AND METHOD TO INCREASE THE PENETRATION OF PRODUCTION FROM THE SEEDS OF CAÑAMO. | |
FR2837705A1 (en) | Use of a mixture of essential oils in cosmetic antiwrinkle products and venous regeneration products | |
EP3506876B1 (en) | Composition for nail fungus | |
CA2745579C (en) | Thick pine needle extract composition for capsulation | |
WO2019080983A1 (en) | Novel formulation based on chitosan and method for producing same | |
RU2680517C1 (en) | Method of the intimate pant therapy and prophylactic cream production | |
RU2400214C1 (en) | Healing and regenerative skin care product | |
ITLI20110005A1 (en) | COMPOSITION FOR THE CARE OF PSORIASIS AND RELATED SKIN DISEASES | |
RU2157175C1 (en) | Natural cream | |
RU2312671C2 (en) | Biologically active supplement "kavelain" for cosmetic articles | |
RO135808A2 (en) | Nourishing regenerating cream with total lipid extract of rapana (rapana venosa) and hemp oil | |
FR2773077A1 (en) | Composition for treatment of wounds and ulcers contains glycerol, sucrose, sorbitol or mannitol | |
FR3015278A1 (en) | OILY MACERATE OF PATIRON (CUCURBITA MAXIMA) FOR A COSMETIC USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |